Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute

Ornellas, Antonio A.; Andrade, Dennyson M.; Ornellas, Paulo; Wisnescky, Aristóteles; Schwindt, Aline B. de Santos.
Int. braz. j. urol ; 38(2): 185-194, Mar.-Apr. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-623332

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Heavy Metal Enlightens Tumor Immunity.
  3. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  4. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  5. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  6. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  7. Molecular differences in renal cell carcinoma between males and females.
  8. Renal cell carcinoma, part 1.
  9. Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis.
  10. Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma.